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Functional thyrotropin receptors (TSH-R) have recently been detected in fat cells but not in liver cells from rat, and it seems that in infant adipocytes stimulatory TSH-R antibodies (TSH-R-ab) act through this receptor pathway, resulting in increased triglyceride catabolism. We investigated the relationships between plasma TSH-R-ab and free thyroxine (FT4) levels (3) (4) (5) . Thyroid hormones act mainly on /3-adrenoceptors but also, to a lesser extent, through their own receptors in adult human adipocytes (6) . High plasma concentra¬ tions of both FFA and glycerol, on the other hand, are effective stimulators of hepatic very low-density lipoprotein (VLDL)-TG synthesis and release (1) .
A second factor acting in the same direction is enhancement of hepatic fatty acid synthesis by thyroid hormones through their own receptors (7) . Further¬ more, thyroid hormone excess increases the fractional removal of endogenous TG (1 ) . Finally, plasma TG levels have been shown to be low (8) , normal (9, 10) (11) . Thyroid hormones seem to increase low-density lipoprotein (LDL) receptor-mediated clear¬ ance of LDL (12), especially at the hepatic level, thus lowering plasma LDL-C concentrations, and the post-heparin plasma hepatic lipase activity is increased leading to decreased plasma high-density lipoprotein (HDL)2-C levels in hyperthyroid patients (13) . Finally, synthesis of apoprotein (apo)-B seems to be decrease in thyrotoxicosis (14) and thyroid hormones reduce plasma total cholesterol (TC) concentrations through increased hepatic catabolism of cholesterol (15) .
In patients with Graves' disease, thyrotropin receptor antibodies (TSH-R-ab) interact with the TSH-R and mimic the action of TSH, leading to thyroid hyperfunction (16) . Furthermore 
